Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03230877 · ClinicalTrials.gov registry record

The Evaluation of a Full Face Mask Seal for the Treatment of Obstructive Sleep Apnea

A clinical trial of Obstructive Sleep Apnea, sponsored by Fisher and Paykel Healthcare.

Completed
Registry status
38
Enrollment target
1
Study location

NCT03230877 is a study of Obstructive Sleep Apnea that has completed, run by Fisher and Paykel Healthcare. The registered enrollment target is 38 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03230877, a study of Obstructive Sleep Apnea, has completed, sponsored by Fisher and Paykel Healthcare.

COMPLETED
Registry status
38 participants
Enrollment target
1
Study location

Study Summary

The investigation is a prospective, randomized, single blinded, crossover study. The investigation is designed to evaluate the performance, comfort and ease of use of the F\&P Trial Full Face Mask Seal amongst Obstructive Sleep Apnea (OSA) participants. A total number of 40-45 OSA participants will be recruited for the trial by the investigation site

Conditions Studied

Interventions

  • DEVICE Toffee full face mask with 'Improved Seal'
  • DEVICE Toffee full face mask with 'Normal Seal'

Study Locations (1)

Florida

  • Clinical Trials of Florida - Miami

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2017-09-02
Est. Completion 2017-11-30

Sponsor

Fisher and Paykel Healthcare

25 total trials

What the Registry Record Tells You About NCT03230877

The ClinicalTrials.gov registry entry for NCT03230877 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (83% lower). The listed sponsor is Fisher and Paykel Healthcare, which has 25 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which Toffee full face mask with 'Improved Seal' is the first listed.

NCT03230877 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03230877 about?

NCT03230877 is a clinical study titled "The Evaluation of a Full Face Mask Seal for the Treatment of Obstructive Sleep Apnea". The investigation is a prospective, randomized, single blinded, crossover study. The investigation is designed to evaluate the performance, comfort and ease of use of the F\&P Trial Full Face Mask Seal amongst Obstructive Sleep Apnea (OSA) participants. A total number of 40-45 OSA participants will ...

What is the current status of trial NCT03230877?

This trial is currently completed. The enrollment target is 38 participants. The study started on 2017-09-02. Estimated completion is 2017-11-30.

What conditions does trial NCT03230877 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT03230877?

The interventions under investigation include: Toffee full face mask with 'Improved Seal' (DEVICE), Toffee full face mask with 'Normal Seal' (DEVICE).

Who is sponsoring clinical trial NCT03230877?

This trial is sponsored by Fisher and Paykel Healthcare, which has 25 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03230877 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.